Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematopoietic development from human embryonic stem cell lines.

Lisheng Wang1, Pablo Menendez, Chantal Cerdan

  • 1Krembil Center for Stem Cell Biology and Regenerative Medicine, Robarts Research Institute, London, Ontario, Canada.

Experimental Hematology
|September 6, 2005
PubMed
Summary

Human embryonic stem cells (hESCs) can generate hematopoietic stem cells (HSCs) in vitro, offering a potential alternative to traditional cell sources. These hESC-derived HSCs show promise for cell-based therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-class segmentation of aortic branches and zones in computed tomography angiography: The AortaSeg24 challenge.

Medical image analysis·2026
Same author

A sequential strategy of upfront radiofrequency ablation followed by endoscopic papillectomy for complex ampullary tumors.

Frontiers in medicine·2026
Same author

Rational design and synthesis of TBC1D2 inhibitors: Augmenting autophagy to improve sorafenib sensitivity in hepatocellular carcinoma.

European journal of medicinal chemistry·2026
Same author

Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicity.

Molecular therapy. Oncology·2026
Same author

PANTHER Challenge Report: Cross-Domain Pancreatic Tumor Segmentation in Magnetic Resonance Imaging.

Medical image analysis·2026
Same author

Undifferentiated pleomorphic sarcoma of the pancreas diagnosed by EUS-guided fine-needle biopsy.

Endoscopic ultrasound·2026

Area of Science:

  • Stem cell biology
  • Hematology
  • Regenerative medicine

Background:

  • Hematopoietic stem cell (HSC) transplantation is a common therapy, but donor availability is limited by compatibility and quantity.
  • Somatic HSCs can be expanded ex vivo, but this compromises their in vivo potential.
  • Human embryonic stem cells (hESCs) have unlimited in vitro proliferation and can differentiate into hematopoietic cells.

Purpose of the Study:

  • To review progress in generating hematopoietic cells from hESCs.
  • To discuss the potential and applications of hESC-derived hematopoietic cells.

Main Methods:

  • hESCs differentiate into hematopoietic cells through specific endothelial precursors (CD45negPFV).
  • These precursors express PECAM-1, Flk-1, and VE-Cadherin.

Related Experiment Videos

  • Characterization of hESC-derived hematopoietic cells' phenotype and function.

    • Main Results:

    • hESC-derived hematopoietic cells emerge from a CD45-negative, PECAM-1, Flk-1, and VE-Cadherin positive endothelial population.
    • These cells exhibit similar clonogenic capacity and primitive phenotype to somatic hematopoietic progenitors.
    • Limited in vivo repopulating capacity in immunodeficient mice suggests HSC-like function.

    Conclusions:

    • hESC-derived hematopoietic cells represent a promising alternative source for transplantation.
    • Further research is needed to optimize differentiation and assess in vivo potential for clinical applications.